Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategy

被引：37

作者：

Hovelson, Daniel H. ^{[1
,2
]}

Liu, Chia-Jen ^{[3
]}

Wang, Yugang ^{[4
]}

Kang, Qing ^{[5
]}

Henderson, James ^{[4
]}

Gursky, Amy ^{[4
]}

Brockman, Scott

Ramnath, Nithya ^{[5
]}

Krauss, John C. ^{[5
]}

Talpaz, Moshe ^{[5
]}

Kandarpa, Malathi ^{[5
]}

Chugh, Rashmi ^{[5
]}

Tuck, Missy ^{[5
]}

Herman, Kirk ^{[5
]}

Grasso, Catherine S. ^{[10
,11
,12
]}

Quist, Michael J. ^{[10
,11
,12
]}

Feng, Felix Y. ^{[13
,14
,15
]}

Haakenson, Christine ^{[16
]}

Langmore, John ^{[16
]}

Kamberov, Emmanuel ^{[16
]}

Tesmer, Tim

Husain, Hatim ^{[17
,18
]}

Lonigro, Robert J. ^{[1
,3
]}

Robinson, Dan ^{[1
,3
,8
]}

Smith, David C. ^{[5
,8
]}

Alva, Ajjai S. ^{[5
,8
]}

Hussain, Maha H. ^{[5
,8
]}

Chinnaiyan, Arul M. ^{[1
,3
,8
,10
,11
]}

Tewari, Muneesh ^{[2
,5
,6
,7
,8
,9
]}

Mills, Ryan E. ^{[2
,7
]}

Morgan, Todd M. ^{[1
,4
,8
]}

Tomlins, Scott A. ^{[1
,3
,4
,8
]}

机构：

[1] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA

[2] Univ Michigan, Sch Med, Dept Computat Med & Bioinformat, Ann Arbor, MI USA

[3] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA

[4] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA

[5] Univ Michigan, Sch Med, Dept Internal Med Hematol Oncol, Ann Arbor, MI USA

[6] Univ Michigan, Sch Med, Dept Biomed Engn, Ann Arbor, MI USA

[7] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI USA

[8] Univ Michigan, Sch Med, Dept Comprehens Canc Ctr, Ann Arbor, MI 48109 USA

[9] Univ Michigan, Sch Med, Dept Biointerfaces Inst, Ann Arbor, MI USA

[10] Univ Calif Los Angeles, Div Hematol Oncol, Los Angeles, CA USA

[11] Jonsson Comprehens Canc Ctr, Los Angeles, CA 90034 USA

[12] Parker Inst Canc Immunotherapy, San Francisco, CA USA

[13] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA USA

[14] Univ Calif San Francisco, Dept Urol, San Francisco, CA USA

[15] Univ Calif San Francisco, Dept Med, San Francisco, CA USA

[16] Takara Bio USA, Ann Arbor, MI USA

[17] Univ Calif San Diego, Moores Canc Ctr, Med Oncol, San Diego, CA 92103 USA

[18] Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA

来源：

ONCOTARGET | 2017年 / 8卷 / 52期

基金：

美国国家卫生研究院;

关键词：

cell-free DNA; precision oncology; prostate cancer; whole genome sequencing; copy-number analysis; INTEGRATIVE CLINICAL GENOMICS; PROSTATE-CANCER; PLASMA DNA; ACTIONABLE MUTATIONS; TUMOR SAMPLES; RESISTANCE; IDENTIFICATION; VALIDATION; HETEROGENEITY; ABERRATIONS;

D O I：

10.18632/oncotarget.21163

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Current cell-free DNA (cfDNA) next generation sequencing (NGS) precision oncology workflows are typically limited to targeted and/or disease-specific applications. In advanced cancer, disease burden and cfDNA tumor content are often elevated, yielding unique precision oncology opportunities. We sought to demonstrate the utility of a pan-cancer, rapid, inexpensive, whole genome NGS of cfDNA approach (PRINCe) as a precision oncology screening strategy via ultra-low coverage (similar to 0.01x) tumor content determination through genome-wide copy number alteration (CNA) profiling. We applied PRINCe to a retrospective cohort of 124 cfDNA samples from 100 patients with advanced cancers, including 76 men with metastatic castration-resistant prostate cancer (mCRPC), enabling cfDNA tumor content approximation and actionable focal CNA detection, while facilitating concordance analyses between cfDNA and tissue-based NGS profiles and assessment of cfDNA alteration associations with mCRPC treatment outcomes. Therapeutically relevant focal CNAs were present in 42 (34%) cfDNA samples, including 36 of 93 (39%) mCRPC patient samples harboring AR amplification. PRINCe identified pre-treatment cfDNA CNA profiles facilitating disease monitoring. Combining PRINCe with routine targeted NGS of cfDNA enabled mutation and CNA assessment with coverages tuned to cfDNA tumor content. In mCRPC, genome-wide PRINCe cfDNA and matched tissue CNA profiles showed high concordance (median Pearson correlation = 0.87), and PRINCe detectable AR amplifications predicted reduced time on therapy, independent of therapy type (Kaplan-Meier log-rank test, chi-square = 24.9, p < 0.0001). Our screening approach enables robust, broadly applicable cfDNA-based precision oncology for patients with advanced cancer through scalable identification of therapeutically relevant CNAs and pre-/post-treatment genomic profiles, enabling cfDNA-or tissue-based precision oncology workflow optimization.

引用

页码：89848 / 89866

页数：19

共 71 条

[1] Gene fusions by chromothripsis of chromosome 5q in the VCaP prostate cancer cell line [J].

Alves, Ines Teles ;

Hiltemann, Saskia ;

Hartjes, Thomas ;

van der Spek, Peter ;

Stubbs, Andrew ;

Trapman, Jan ;

Jenster, Guido .

HUMAN GENETICS, 2013, 132 (06) :709-713

[2] Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing [J].

Amant, Frederic ;

Verheecke, Magali ;

Wlodarska, Iwona ;

Dehaspe, Luc ;

Brady, Paul ;

Brison, Nathalie ;

Van den Bogaert, Kris ;

Dierickx, Daan ;

Vandecaveye, Vincent ;

Tousseyn, Thomas ;

Moerman, Philippe ;

Vanderstichele, Adriaan ;

Vergote, Ignace ;

Neven, Patrick ;

Berteloot, Patrick ;

Putseys, Katrien ;

Danneels, Lode ;

Vandenberghe, Peter ;

Legius, Eric ;

Vermeesch, Joris Robert .

JAMA ONCOLOGY, 2015, 1 (06) :814-819

[3]

[Anonymous], AN READ STAND TCGA D, DOI 10.7908/C11G0KM9

[4] AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer [J].

Antonarakis, Emmanuel S. ;

Lu, Changxue ;

Wang, Hao ;

Luber, Brandon ;

Nakazawa, Mary ;

Roeser, Jeffrey C. ;

Chen, Yan ;

Mohammad, Tabrez A. ;

Chen, Yidong ;

Fedor, Helen L. ;

Lotan, Tamara L. ;

Zheng, Qizhi ;

De Marzo, Angelo M. ;

Isaacs, John T. ;

Isaacs, William B. ;

Nadal, Rosa ;

Paller, Channing J. ;

Denmeade, Samuel R. ;

Carducci, Michael A. ;

Eisenberger, Mario A. ;

Luo, Jun .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (11) :1028-1038

[5] Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer [J].

Azad, Arun A. ;

Volik, Stanislav V. ;

Wyatt, Alexander W. ;

Haegert, Anne ;

Le Bihan, Stephane ;

Bell, Robert H. ;

Anderson, Shawn A. ;

McConeghy, Brian ;

Shukin, Robert ;

Bazov, Jenny ;

Youngren, Jack ;

Paris, Pamela ;

Thomas, George ;

Small, Eric J. ;

Wang, Yuzhuo ;

Gleave, Martin E. ;

Collins, Colin C. ;

Chi, Kim N. .

CLINICAL CANCER RESEARCH, 2015, 21 (10) :2315-2324

[6] Investigation of 305 patients with myelodysplastic syndromes and 20q deletion for associated cytogenetic and molecular genetic lesions and their prognostic impact [J].

Bacher, Ulrike ;

Haferlach, Torsten ;

Schnittger, Susanne ;

Zenger, Melanie ;

Meggendorfer, Manja ;

Jeromin, Sabine ;

Roller, Andreas ;

Grossmann, Vera ;

Krauth, Maria-Theresa ;

Alpermann, Tamara ;

Kern, Wolfgang ;

Haferlach, Claudia .

BRITISH JOURNAL OF HAEMATOLOGY, 2014, 164 (06) :822-833

[7] Combining Highly Multiplexed PCR with Semiconductor-Based Sequencing for Rapid Cancer Genotyping [J].

Beadling, Carol ;

Neff, Tanaya L. ;

Heinrich, Michael C. ;

Rhodes, Katherine ;

Thornton, Michael ;

Leamon, John ;

Andersen, Mark ;

Corless, Christopher L. .

JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (02) :171-176

[8] Rapid Identification of Plasma DNA Samples with Increased ctDNA Levels by a Modified FAST-SeqS Approach [J].

Belic, Jelena ;

Koch, Marina ;

Ulz, Peter ;

Auer, Martina ;

Gerhalter, Teresa ;

Mohan, Sumitra ;

Fischereder, Katja ;

Petru, Edgar ;

Bauernhofer, Thomas ;

Geigl, Jochen B. ;

Speicher, Michael R. ;

Heitzer, Ellen .

CLINICAL CHEMISTRY, 2015, 61 (06) :838-849

[9] Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer [J].

Beltran, Himisha ;

Prandi, Davide ;

Mosquera, Juan Miguel ;

Benelli, Matteo ;

Puca, Loredana ;

Cyrta, Joanna ;

Marotz, Clarisse ;

Giannopoulou, Eugenia ;

Chakravarthi, Balabhadrapatruni V. S. K. ;

Varambally, Sooryanarayana ;

Tomlins, Scott A. ;

Nanus, David M. ;

Tagawa, Scott T. ;

Van Allen, Eliezer M. ;

Elemento, Olivier ;

Sboner, Andrea ;

Garraway, Levi A. ;

Rubin, Mark A. ;

Demichelis, Francesca .

NATURE MEDICINE, 2016, 22 (03) :298-305

[10] Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies [J].

Bettegowda, Chetan ;

Sausen, Mark ;

Leary, Rebecca J. ;

Kinde, Isaac ;

Wang, Yuxuan ;

Agrawal, Nishant ;

Bartlett, Bjarne R. ;

Wang, Hao ;

Luber, Brandon ;

Alani, Rhoda M. ;

Antonarakis, Emmanuel S. ;

Azad, Nilofer S. ;

Bardelli, Alberto ;

Brem, Henry ;

Cameron, John L. ;

Lee, Clarence C. ;

Fecher, Leslie A. ;

Gallia, Gary L. ;

Gibbs, Peter ;

Le, Dung ;

Giuntoli, Robert L. ;

Goggins, Michael ;

Hogarty, Michael D. ;

Holdhoff, Matthias ;

Hong, Seung-Mo ;

Jiao, Yuchen ;

Juhl, Hartmut H. ;

Kim, Jenny J. ;

Siravegna, Giulia ;

Laheru, Daniel A. ;

Lauricella, Calogero ;

Lim, Michael ;

Lipson, Evan J. ;

Marie, Suely Kazue Nagahashi ;

Netto, George J. ;

Oliner, Kelly S. ;

Olivi, Alessandro ;

Olsson, Louise ;

Riggins, Gregory J. ;

Sartore-Bianchi, Andrea ;

Schmidt, Kerstin ;

Shih, Ie-Ming ;

Oba-Shinjo, Sueli Mieko ;

Siena, Salvatore ;

Theodorescu, Dan ;

Tie, Jeanne ;

Harkins, Timothy T. ;

Veronese, Silvio ;

Wang, Tian-Li ;

Weingart, Jon D. .

SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (224)

← 1 2 3 4 5 6 7 8 →